natgillin/translations-raw huggingface dataset:
There are no controlled trials demonstrating a clinical benefit, such as improvement in disease-related symptoms or increased survival. 
Razen za na novo diagnosticirano KML v kronični fazi ni kontroliranih kliničnih preskušanj, ki bi dokazovala klinično koristnost, na primer izboljšanje bolezenskih simptomov ali povečano preživetje.
Total bilirubin: = 1.5 ULN AST: >ULN (can be normal or <ULN if total bilirubin is >ULN) 
AST: > IULN (lahko je normalna ali < IULN, če je celotni bilirubin > IULN) celotni bilirubin: > 1,5-3,0 IULN AST: kakršnakoli celotni bilirubin: > 3-10 IULN AST: kakršnakoli
Substances that are inducers of CYP3A4 activity (e.g. dexamethasone, phenytoin, carbamazepine, rifampicin, phenobarbital, fosphenytoin, primidone or Hypericum perforatum, also known as St. John's Wort) may significantly reduce exposure to imatinib, potentially increasing the risk of therapeutic failure. 
Snovi, ki inducirajo aktivnost CYP3A4 (na primer deksametazon, fenitoin, karbamazepin, rifampicin, fenobarbital, fosfenitoin, primidon ali Hypericum perforatum, znan tudi pod imenom šentjanževka), lahko znatno zmanjšajo izpostavljenost imatinibu in s tem potencialno povečajo tveganje za neuspešnost zdravljenja.
If your daily dose is 800 mg (8 tablets), you should take 4 tablets in the morning and 4 tablets in 
Če je vaš dnevni odmerek 800 mg (8 tablet), morate vzeti 4 tablete zjutraj in 4 tablete zvečer.
Hepatic insufficiency: Imatinib is mainly metabolised through the liver. 
Imatinib se presnavlja predvsem v jetrih.
Non transparent orange capsules with black marking 7630 on capsule body and black marking TEVA on capsule cap. 
Neprozorna oranžna kapsula, s črno oznako 7630 na telesu in s črno oznako TEVA na pokrovčku kapsule.
The adult patients reported in the published literature were treated with either 400 mg (4 cases) or 800 mg (1 case) imatinib daily. 
Odrasli bolniki, o katerih so pisali v objavljeni literaturi, so bili zdravljeni z odmerki bodisi 400 mg (v 4 primerih) ali pa 800 mg (v 1 primeru) imatiniba na dan. Do odziva je prišlo pri petih (5) bolnikih, pri 3 do popolnega in pri 2 do delnega.
Dose increases from 340 mg/m2 daily to 570 mg/m2 daily (not to exceed the total dose of 800 mg) may be considered in children in the absence of severe adverse drug reaction and severe non-leukaemia-related neutropenia or thrombocytopenia in the following circumstances: disease progression (at any time); failure to achieve a satisfactory haematological response after at least 3 months of treatment; failure to achieve a cytogenetic response after 12 months of treatment; or loss of a previously achieved haematological and/or cytogenetic response. 
mg) pride v poštev pri otrocih, ki nimajo hudih neželenih učinkov na zdravilo in hude nevtropenije ali trombocitopenije, ki bi bila povezana z levkemijo, in sicer v sledečih okoliščinah: napredovanje bolezni (kadarkoli); odsotnost zadovoljivega hematološkega odziva po najmanj 3 mesecih zdravljenja; odsotnost citogenetičnega odziva po 12 mesecih zdravljenja; ali izguba že prej doseženega hematološkega ali citogenetičnega odziva ali obojega.
The dose is 800 mg per day (2 capsules), to be taken as one capsule in the morning and a second capsule in the evening. 
Odmerek je 800 mg na dan (2 kapsuli), ki ga vzamete kot eno kapsulo zjutraj in eno kapsulo
A second multicentre, open label phase III study (SSG XVIII/AIO) compared 400 mg/day imatinib 12 months treatment vs. 36 months treatment in patients after surgical resection of GIST and one of the following: tumour diameter > 5 cm and mitotic count > 5/50 high power fields (HPF); or tumour diameter > 10 cm and any mitotic count or tumour of any size with mitotic count > 10/50 HPF or tumours ruptured into the peritoneal cavity. 
GIST z eno od naslednjih možnosti: premer tumorja > 5 cm in število mitoz > 5/50 v vidnem polju mikroskopa pri veliki povečavi (HPF - high power fields) ali premer tumorja > 10 cm in kakršnokoli število mitoz ali kakršnakoli velikost tumorja in število mitoz > 10/50 HPF ali pa razpok tumorja v peritonealno votlino.
The age of these patients ranged from 2 to 16 years and imatinib was given at dose 300 mg/m2 daily or doses ranging from 200 to 400 
Ti bolniki so bili stari od 2 do 16 let, imatinib pa so prejemali v odmerku 300 mg/m2 na dan ali v odmerkih od 200 mg do 400 mg na dan.
Description of selected adverse reactions: 
otekanje sklepov občasni:
Pack sizes of 30x1 or 90x1 film-coated tablets in perforated unit dose blisters. 
Škatle, ki vsebujejo po 30x1 ali 90x1 filmsko obloženih tablet v perforiranem pretisnem omotu za
In children and adolescents, Imatinib Teva B.V. can be used in different phases of the disease (chronic, accelerated phase and blast crisis). 
uporablja za zdravljenje vseh faz te bolezni (kronični, pospešeni fazi in blastni krizi).
CML (CML-AP and CML-BC) than in patients with chronic CML. 
KML (kronična mieloična levkemija v pospešeni fazi: KML-AP in kronična mieloična levkemija v blastni krizi: KML-BC) kot pri bolnikih s kroničnim potekom KML.
Headache2 
jemati
The usual starting dose is 600 mg to be taken as one capsule of 400 mg plus 2 capsules of 100 mg 
Običajni začetni odmerek je 600 mg, ki ga vzamete kot eno kapsulo po 400 mg in še 2 kapsuli
When and how to take Imatinib Teva B.V. - Take Imatinib Teva B.V. with a meal. 
Kdaj in kako jemati zdravilo Imatinib Teva B.V.
There is very limited experience in children with MDS/MPD, DFSP, GIST 
Izkušnje pri otrocih z MDS/MPD, DFSP in HES/CEL so zelo omejene.
Herpes zoster, herpes simplex, nasopharyngitis, pneumonia1, sinusitis, cellulitis, upper respiratory tract infection, influenza, urinary tract 
Preglednica 1 Preglednica neželenih učinkov herpes zoster, herpes simpleks, nazofaringitis, pljučnica1, sinuzitis, flegmona, okužba zgornjih dihal, gripa, okužba sečil, gastroenteritis, sepsa redki:
Pack sizes of 20x1, 60x1, 120x1 or 180x1 film-coated tablets in perforated unit dose blisters. 
Škatle, ki vsebujejo po 20x1, 60x1, 120x1 ali 180x1 filmsko obloženih tablet v perforiranem pretisnem omotu za posamezne odmerke.
Imatinib Teva B.V. 400 mg hard capsules are non-transparent orange capsules with black marking 7630 on capsule body and black marking TEVA on capsule cap. 
400 mg trde kapsule so neprozorne oranžne kapsule s črno oznako 7630 na telesu in s črno oznako TEVA na pokrovčku kapsule.
In two clinical studies (study B2222 and an intergroup study S0033) the daily dose of imatinib was escalated to 800 mg in patients progressing at the lower daily doses of 400 mg or 600 mg. 
V dveh kliničnih študijah (študija B2222 in študija med skupinami S0033) so pri bolnikih, pri katerih je pri manjših odmerkih 400 mg ali 600 mg na dan, bolezen napredovala, zvečali odmerek imatiniba na 800 mg na dan. Odmerek so zvečali na 800 mg na dan pri vsega skupaj 103 bolnikih; po zvečanju odmerka je 6 bolnikov doseglo delni odziv, 21 pa stabilizacijo svoje bolezni, kar je pomenilo celotno klinično koristnost 26 %.
9 Musculoskeletal pain during treatment with imatinib or after discontinuation has been observed in 
9 V obdobju trženja zdravila so opažali mišično-skeletne bolečine med zdravljenjem z imatinibom ali po prekinitvi zdravljenja.
The dose is 800 mg per day (2 tablets), to be taken as one tablet in the morning and a second tablet in the evening. 
Odmerek je 800 mg na dan (2 tableti), ki ga vzamete kot eno tableto zjutraj in eno tableto
• Mouth ulcers. 
(imenovane eozinofilci).
- if you are taking the medicine levothyroxine because your thyroid has been removed. 
- če imate ali ste kdaj imeli težave z jetri, ledvicami ali srcem; - če jemljete zdravilo levotiroksin, ker so vam odstranili ščitnico.
Tumour lysis syndrome 
Limfoidna blastna kriza
The risk of recurrence was thus reduced by approximately 89% as compared with placebo (hazard ratio = 0.113 [0.049-0.264]). 
Tveganje za ponovitev bolezni je bilo torej zmanjšano za približno 89% v primerjavi s placebom (razmerje tveganj
For adult patients with relapsed or refractory Ph+ALL imatinib monotherapy at 600 mg/day is safe, effective and can be given until disease progression occurs. 
Za odrasle bolnike z relapsom ali neodzivno Ph+ ALL je imatinib kot monoterapija v odmerku 600
(1 h), days 28-31, 35-38, 42-45; 6-MP 60 mg/m2 oral, days 26-46 
(1 ura), 28.-31., 35.-38., 42.-45. dan; 6-MP 60 mg/m2 peroralno, 26.-46. dan DEX 10 mg/m2 peroralno, 1.-5. dan; vindezin 3 mg/m2 i.v., 1. dan;
The dose can be reduced if not tolerated (see section 4.2 and 5.2). 
če ga bolnik ne prenaša dobro (glejte poglavji 4.2 in 5.2).
If your daily dose is 800 mg (8 capsules), you should take 4 capsules in the morning and 4 
Če je vaš dnevni odmerek 800 mg (8 kapsul), morate vzeti 4 kapsule
Very common: 
pogosti:
ANC ≥ 1 x 109/l and platelets ≥ 20 x 109/l, 
NEL enaki kriteriji kot za CHR, a ANC ≥ 1 x 109/l in trombociti ≥ 20 x 109/l
• Muscle spasms with a fever, red-brown urine, pain or weakness in your muscles (signs of muscle 
• bolečine v želodcu z občutkom slabosti s siljenjem na bruhanje (navzea), • mišični spazmi z vročino, rdeče-rjavo obarvan urin, boleče ali oslabele mišice (znaki težav z
The recommended dose of Imatinib Teva B.V. is 600 mg/day for adult patients with Ph+ ALL. 
pri odraslih bolnikih s Ph+ ALL je 600 mg/dan.
Depression, libido decreased, anxiety 
hiperkaliemija, hipomagneziemija nespečnost depresija, zmanjšan libido, anksioznost zmedenost glavobol2
Rash pustular, contusion, sweating increased, urticaria, ecchymosis, increased tendency to bruise, hypotrichosis, skin hypopigmentation, dermatitis exfoliative, onychoclasis, folliculitis, petechiae, psoriasis, purpura, skin hyperpigmentation, bullous eruptions 
urtikarija, ekhimoza, nagnjenost k podplutbam, hipotrihoza, hipopigmentacija kože, eksfoliativni dermatitis, lomljenje nohtov, folikulitis, petehije, psoriaza, purpura, hiperpigmentacija kože, bulozne erupcije akutna febrilna nevtrofilna dermatoza (Sweetov sindrom), sprememba barve nohtov,
The usual starting dose is 600 mg to be taken as one tablet of 400 mg plus 2 tablets of 100 mg once a 
Začetni odmerek je 600 mg, ki ga vzamete kot eno tableto po 400 mg in še 2 tableti po 100 mg enkrat na dan.
Psychiatric disorders Common: 
anoreksija občasni:
If your daily dose is 800 mg (2 tablets), you should take one tablet in the morning and a second 
Če je vaš dnevni odmerek 800 mg (2 tableti), morate vzeti 1 tableto zjutraj in 1 tableto zvečer.
Vindesine 3 mg/m2 i.v., day 1; 
VCR 1,3 g/m2 i.v., 1. dan;
Blood creatinine increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, blood alkaline phosphatase 
bolečine v prsnem košu, slabo počutje zvečanje telesne mase zmanjšanje telesne mase zvišana vrednost kreatinina v krvi, zvišana vrednost kreatin-kinaze v krvi, zvišana vrednost laktat-dehidrogenaze v krvi, zvišana vrednost alkalne fosfataze v krvi zvišana vrednost amilaze v krvi
Table 4 Chemotherapy regimen used in combination with imatinib in study I2301 
Preglednica 4 Kemoterapevtske sheme, uporabljene v kombinaciji z imatinibom v
Your doctor will tell you exactly how many tablets of Imatinib Teva B.V. to take. 
Zdravnik vam bo natančno povedal, koliko tablet zdravila Imatinib Teva B.V.
The usual starting dose is 600 mg to be taken as 6 tablets once a day. 
Običajni začetni odmerek je 600 mg, ki ga vzamete kot 6 tablet enkrat na dan.
Imatinib Teva B.V. inhibits the growth of these cells in a certain subtype of these diseases. 
zavira rast teh celic pri določenih podskupinah teh bolezni.
Imatinib Teva B.V. 100 mg film-coated tablets Pack sizes of 60 or 120 film-coated tablets in blisters. 
100 mg filmsko obložene tablete Škatle, ki vsebujejo po 60 ali 120 filmsko obloženih tablet v pretisnem omotu.
The starting dose is 100 mg, to be taken as one capsule of 100 mg once a day. 
Začetni odmerek je 100 mg, ki ga vzamete kot eno kapsulo po 100 mg enkrat na dan.
• Pain or swelling in your abdomen, flatulence, heartburn or constipation. 
• bolečine v trebuhu ali napihnjen trebuh, vetrovi, zgaga ali zapeka, • neobičajno izpadanje ali tanjšanje las,
If your daily dose is 800 mg (2 capsules), you should take one capsule in the morning and a 
Če je vaš dnevni odmerek 800 mg (2 kapsuli), morate vzeti eno kapsulo zjutraj in eno kapsulo zvečer.
Hypertension, haematoma, subdural haematoma, peripheral coldness, 
hipertenzija, hematom, subduralni hematom, hladni distalni deli udov, hipotenzija, Raynaudov fenomen pogostnost neznana:
Talk to your doctor before taking Imatinib Teva B.V.: - if you have or have ever had a liver, kidney or heart problem. 
se posvetujte z zdravnikom: - če imate ali ste kdaj imeli težave z jetri, ledvicami ali srcem; - če jemljete zdravilo levotiroksin, ker so vam odstranili ščitnico.
The recommended dose of Imatinib Teva B.V. is 400 mg/day for adult patients with unresectable and/or metastatic malignant GIST. 
pri odraslih bolnikih z neresektabilnimi in/ali metastatskimi malignimi GIST je 400 mg/dan.
The starting dose is 100 mg, to be taken as one tablet of 100 mg once a day. 
Začetni odmerek je 100 mg, ki ga vzamete kot eno tableto po 100 mg enkrat na dan.
Population pharmacokinetics 
5.1 Farmakodinamične lastnosti
Imatinib Teva B.V. 400 mg film-coated tablets 
400 mg filmsko obložene tablete imatinib
Hypokalaemia, increased appetite, hypophosphataemia, decreased appetite, dehydration, gout, hyperuricaemia, hypercalcaemia, hyperglycaemia, hyponatraemia 
zmanjšan apetit, dehidracija, protin, hiperurikemija, hiperkalciemija, hiperglikemija, hiponatriemija hiperkaliemija, hipomagneziemija nespečnost depresija, zmanjšan libido, anksioznost zmedenost glavobol2
Treatment with imatinib for 36 months was superior to treatment for 12 months in the ITT analysis, i.e. including the entire study population. 
Rezultati analize ITT, ki obsega celotno študijsko populacijo, kažejo, da je 36-mesečno zdravljenje z imatinibom boljše od 12-mesečnega zdravljenja.
• Discharge from the eye with itching, redness and swelling (conjunctivitis), watery eyes or having blurred vision. 
• izcedek iz oči s srbenjem, rdečino in otekanjem (vnetje očesne veznice), prekomerno solzenje ali
RFS 
AFIP
Hypokalaemia, increased appetite, hypophosphataemia, decreased appetite, dehydration, gout, hyperuricaemia, hypercalcaemia, 
zmanjšan apetit, dehidracija, protin, hiperurikemija, hiperkalciemija, hiperglikemija, hiponatriemija redki:
Imatinib Teva B.V. 100 mg film-coated tablets Each film-coated tablet contains 100 mg of imatinib (as mesilate). 
100 mg filmsko obložene tablete Ena filmsko obložena tableta vsebuje 100 mg imatiniba (v obliki mesilata).
The usual starting dose is 600 mg to be taken as 6 capsules once a day. 
Običajni začetni odmerek je 600 mg, ki ga vzamete kot 6 kapsul enkrat na dan.
RFS rates (%) 12 month 24 month Imatinib vs placebo 
delež bolnikov s preživetjem brez ponovitve bolezni (%) 12 mesecev 24 mesecev imatinib v primerjavi s placebom imatinib v primerjavi s placebom
Your doctor will tell you exactly how many capsules of Imatinib Teva B.V. to take. 
Zdravnik vam bo natančno povedal, koliko kapsul zdravila Imatinib Teva B.V.
In the event of recurrence of ANC < 1.0 x 109/l and/or platelets < 50 x 109/l, repeat step 1 and resume imatinib at reduced dose of 260 mg/m2. 
Če se pojav/a ANC < 1,0 x 109/l in/ali koncentracija trombocitov < 50 x 109/l ponovi/ta, ponovite točko 1 in spet začnite zdravljenje z imatinibom z zmanjšanim odmerkom 260 mg/m2.
Imatinib Teva B.V. 400 mg film-coated tablets are available in pack sizes of 30 or 90 film-coated tablets in blisters. 
400 mg filmsko obložene tablete je pakirano v škatli po 30 ali 90 filmsko Zdravilo Imatinib Teva B.V.
No overall survival benefit has been observed. 
vendar vpliv tega pojava na celotno preživetje še vedno ni znan.
When given with a high-fat meal, the rate of absorption of imatinib was minimally reduced (11% decrease in Cmax and prolongation of tmax by 1.5 h), with a small reduction in 
Če so imanitib dajali z zelo mastnim obrokom, se je obseg njegove absorpcije minimalno zmanjšal (Cmax se je zmanjšala za
Imatinib Teva B.V. 100 mg film-coated tablets 
100 mg filmsko obložene tablete imatinib
Imatinib Teva B.V. 100 mg film-coated tablets are available in pack sizes of 20x1, 60x1, 120x1 or 180x1 film-coated tablets in perforated unit dose blisters. 
100 mg filmsko obložene tablete je pakirano v škatli po 20x1, 60x1, 120x1 ali 180x1 v perforiranih pretisnih omotih za posamezne odmerke.
Imatinib Teva B.V. 100 mg hard capsules are available in pack sizes of 60 or 120 hard capsules in blisters. 
100 mg trde kapsule je pakirano v škatli po 60 ali 120 trdih kapsul v Zdravilo Imatinib Teva B.V.
Imatinib Teva B.V. 100 mg hard capsules are non-transparent orange capsules with black marking 7629 on capsule body and black marking TEVA on capsule cap. 
100 mg trde kapsule so neprozorne oranžne kapsule s črno oznako 7629
Imatinib Teva B.V. 400 mg film-coated tablets Each film-coated tablet contains 400 mg of imatinib (as mesilate). 
400 mg filmsko obložene tablete Ena filmsko obložena tableta vsebuje 400 mg imatiniba (v obliki mesilata).
Imatinib adverse events, i.e. hepatotoxicity, myelosuppression or others, may increase and it has been reported that concomitant use with L-asparaginase could be associated with increased hepatotoxicity (see section 4.8). 
Poročali so, da bi bila lahko sočasna uporaba L asparaginaze povezana z bolj izraženo toksičnostjo za jetra (glejte poglavje 4.8).
Flatulence, abdominal distension, gastro-oesophageal reflux, constipation, Stomatitis, mouth ulceration, gastrointestinal haemorrhage7, eructation, melaena, oesophagitis, ascites, gastric ulcer, haematemesis, cheilitis, Colitis, ileus, inflammatory bowel disease Ileus/intestinal obstruction*, gastrointestinal perforation*, diverticulitis*, gastric antral vascular ectasia (GAVE)* 
disfagija, pankreatitis kolitis, ileus, vnetna bolezen črevesa ileus/zapora črevesja*, gastrointestinalna perforacija*, divertikulitis*, žilne ektazije antruma želodca (GAVE)*
G-CSF (5 μg/kg, SC): days 5-14 or until ANC > 1500 post nadir Triple IT therapy (age-adjusted): days 1 and 15 
G-CSF (5 μg/kg, s.c.): 5.-14. dan oziroma do ANC > 1500 po doseženem trojno i.t.
NAME OF THE MEDICINAL PRODUCT Imatinib Teva B.V. 100 mg hard capsules Imatinib Teva B.V. 400 mg hard capsules 
100 mg trde kapsule Imatinib Teva B.V.
Imatinib Teva B.V. 400 mg film-coated tablets Pack sizes of 30 or 90 film-coated tablets in blisters. 
400 mg filmsko obložene tablete Škatle, ki vsebujejo po 30 ali 90 filmsko obloženih tablet v pretisnem omotu.
G-CSF (5 μg/kg, SC): days 27-36 or until ANC > 1500 post nadir ARA-C (3 g/m2, q12h, IV): days 43, 44 
): 22.-26. dan G-CSF (5 μg/kg, s.c.): 27.-36. dan oziroma do ANC > 1500 po doseženem
Liver function tests 
Moteno delovanje organov
Pack sizes of 20x1, 60x1, 120x1 or 180x1 hard capsules in perforated unit dose blisters. 
Škatla, ki vsebuje po 20x1, 60x1, 120x1 ali 180x1 trdih kapsul v perforiranem pretisnem omotu za
a ANC < 0.5 x 109/l and/or platelets < 10 x 109/l 
aANC < 0,5 x 109/l in/ali koncentracija trombocitov
Imatinib Teva B.V. 100 mg film-coated tablets are dark yellow to brownish orange round film-coated tablets with a score line on one side. 
100 mg filmsko obložene tablete Temno rumena do rjavkastooranžna filmsko obložena tableta, okrogla in z zarezo na eni strani.
Stomatitis, mouth ulceration, gastrointestinal haemorrhage7, eructation, melaena, oesophagitis, ascites, gastric ulcer, haematemesis, cheilitis, 
flatulenca, napihnjen trebuh, gastroezofagealni refluks, obstipacija, suha usta, gastritis stomatitis, razjede ustne sluznice, krvavitev iz prebavil7, spahovanje, melena, ezofagitis, ascites,
Palpitations, tachycardia, cardiac failure congestive3, pulmonary oedema Arrhythmia, atrial fibrillation, cardiac arrest, myocardial infarction, 
Ušesne bolezni, vključno z motnjami labirinta vrtoglavica, zvonjenje v ušesih, izguba sluha palpitacije, tahikardija, kongestivno popuščanje srca3, pljučni edem aritmija, atrijska fibrilacija, zastoj srca, miokardni infarkt, angina pektoris, perikardialni izliv perikarditis*, tamponada srca*
The starting dose is 100 mg, to be taken as one capsule once a day. 
Začetni odmerek je 100 mg, ki ga vzamete kot eno kapsulo enkrat na dan.
The starting dose is 400 mg, to be taken as one capsule once a day. 
Začetni odmerek je 400 mg, ki ga vzamete kot eno kapsulo enkrat na dan.
The doctor will tell you how many tablets of Imatinib Teva B.V. to give to your child. 
Zdravnik vam bo povedal, koliko tablet zdravila Imatinib Teva B.V.
These are blood diseases in which some blood cells (named eosinophils) start growing out of control. 
To so bolezni krvi, pri katerih se začnejo nenadzorovano razraščati nekatere krvne celice
Not known: 
je indicirano za:
NAME OF THE MEDICINAL PRODUCT Imatinib Teva B.V. 100 mg film-coated tablets Imatinib Teva B.V. 400 mg film-coated tablets 
100 mg filmsko obložene tablete Imatinib Teva B.V.
6.6 Special precautions for disposal 
6.1 Seznam pomožnih snovi
Your doctor may decide to increase the dose to 400 mg, to be taken as 4 tablets once a day, depending on how you respond to treatment. 
Zdravnik se lahko odloči za zvečanje odmerka na 400 mg, ki ga vzamete kot 4 tablete enkrat na dan, odvisno od vašega odziva na zdravljenje.
Anaphylactic shock* Blood and lymphatic system disorders 
anafilaktični šok*
(q 12 h), days 2-3, for 4 cycles VCR 1.3 g/m2 i.v., day 1; 
ur), 2.-3. dan, v 4 ciklusih VCR 1,3 g/m2 i.v., 1. dan; prednizolon 60 mg/m2
Your doctor may decide to increase the dose to 400 mg, to be taken as one capsule of 400 mg once a day, depending on how you respond to treatment. 
Zdravnik se lahko odloči za zvečanje odmerka na 400 mg, ki ga vzamete kot eno kapsulo po 400 mg enkrat na dan, odvisno od vašega odziva na zdravljenje.
The printing ink is composed of shellac, iron oxide black (E172) and propylene glycol. 
Tiskarska barva pa vsebuje šelak, črni železov oksid (E172) in
Imatinib Teva B.V. 400 mg hard capsules are available in pack sizes of 30x1 or 90x1 hard capsules in perforated unit dose blisters. 
400 mg trde kapsule je pakirano v škatli po 30x1 ali 90x1 trdih kapsul v perforiranem pretisnem omotu za posamezne odmerke.
The starting dose is 100 mg, to be taken as one tablet once a day. 
Začetni odmerek je 100 mg, ki ga vzamete kot eno tableto enkrat na dan.
The starting dose is 400 mg, to be taken as one tablet once a day. 
Začetni odmerek je 400 mg, ki ga vzamete kot eno tableto enkrat na dan.
Your doctor may decide to increase the dose to 400 mg, to be taken as 4 capsules once a day, depending on how you respond to treatment. 
Zdravnik se lahko odloči za zvečanje odmerka na 400 mg, ki ga vzamete kot 4 kapsule enkrat na dan, odvisno od vašega odziva na zdravljenje.
Pack sizes of 30x1 or 90x1 hard capsules in perforated unit dose blisters. 
Škatla, ki vsebuje po 30x1 ali 90x1 trdih kapsul v perforiranem pretisnem omotu za posamezne
This is because Imatinib Teva B.V. 
Zaradi zdravila Imatinib Teva B.V.
Your doctor may decide to increase the dose to 400 mg, to be taken as one tablet of 400 mg once a day, depending on how you respond to treatment. 
Zdravnik se lahko odloči za zvečanje odmerka na 400 mg, ki ga vzamete kot eno tableto po 400 mg enkrat na dan, odvisno od vašega odziva na zdravljenje.
All 65 
do 59).
Methylprednisolone 40 mg intrathecal, days 1, 8, 15, 22 Ara-C 1,000 mg/m2/12 h i.v. 
Ara-C 40 mg intratekalno, 1., 8., 15., 22. dan; metilprednizolon 40 mg intratekalno, 1., 8., 15., 22. dan Konsolidacija (novo odkrita Ph+ ALL) Ara-C 1.000 mg/m2/12 ur i.v.
Imatinib Teva B.V. 400 mg hard capsules are available in pack sizes of 30 or 90 hard capsules in blisters. 
400 mg trde kapsule je pakirano v škatli po 30 ali 90 trdih kapsul v Zdravilo Imatinib Teva B.V.
Imatinib vs placebo 
AUC imatiniba.
CP 1 g/m2 i.v. 
Ara-C 1 g/m2 i.v.
Imatinib Teva B.V. 100 mg film-coated tablets are available in pack sizes of 60 or 120 film-coated tablets in blisters. 
100 mg filmsko obložene tablete je pakirano v škatli po 60 ali 120 filmsko obloženih tablet v pretisnem omotu.
If you have any questions about how Imatinib Teva B.V. works or why this medicine has been prescribed for you, ask your doctor. 
Če imate kakšna vprašanja glede tega, kako zdravilo Imatinib Teva B.V.